跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP
Authorized
STANDARD
METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP
sterinova inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5f85dfe40e9000d3
Company
sterinova inc.
Type
Standard
Approval Details
Approval Id
5f85dfe40e9000d3
Drug Approval Canada Name
METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP
Product Name
METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP
Status
Cancelled Post Market
Status Date
2022-02-08
Original Market Date
2019-07-30
Din
02481979
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N07BC02 METHADONE
Atc Name
n 07 bc 02
Aig Number
0144621001
Company Name
sterinova inc.
Company Address
3005 Avenue Jose-Maria Rosell, Saint-Hyacinthe, Quebec, Canada, J2S 0J9
Active Ingredients
METHADONE HYDROCHLORIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5f85dfe40e9000d3
Type
Standard
Back to Health Canada Approvals